Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2006 1
2009 2
2010 1
2011 5
2012 3
2013 3
2014 4
2015 3
2016 10
2017 6
2018 1
2019 5
2020 3
2021 6
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Opioid-Induced Constipation and Acupuncture: A Case Discussion.
Olson EA, Metzger AK, Mallory MJ, Mackey RM. Olson EA, et al. J Pain Symptom Manage. 2021 Oct;62(4):876-880. doi: 10.1016/j.jpainsymman.2021.01.135. Epub 2021 Feb 5. J Pain Symptom Manage. 2021. PMID: 33556492
Pain management required use of opioids, escalating to effect. Hospital course was complicated by opioid-induced constipation causing abdominal pain, nausea, and ileus despite aggressive titration of stimulant and osmotic laxatives as well as administration of suppositorie …
Pain management required use of opioids, escalating to effect. Hospital course was complicated by opioid-induced constipation causing …
Rethinking Docusate's Role in Opioid-Induced Constipation: A Critical Analysis of the Evidence.
Engle AL, Winans ARM. Engle AL, et al. J Pain Palliat Care Pharmacother. 2021 Mar;35(1):63-72. doi: 10.1080/15360288.2020.1828529. Epub 2021 Feb 17. J Pain Palliat Care Pharmacother. 2021. PMID: 33596159 Review.
Opioid induced constipation (OIC) is a predictable and preventable adverse effect of opioid use. Docusate is often utilized for OIC prophylaxis and treatment because of its low cost, easy accessibility and tolerability. ...
Opioid induced constipation (OIC) is a predictable and preventable adverse effect of opioid use. Docusate is often utilized for OIC p …
Opioid-induced constipation in mixed chronic pain patients: Prevalence and predictors analysis.
Samolsky Dekel BG, Sorella MC, Vasarri A, Gori A, Melotti RM. Samolsky Dekel BG, et al. J Opioid Manag. 2019 Sep/Oct;15(5):375-387. doi: 10.5055/jom.2019.0527. J Opioid Manag. 2019. PMID: 31849029
OBJECTIVES: Assessment of opioid-induced constipation (OIC) prevalence and relationship with demographic, clinical, and drug predictors in our daily practice. DESIGN: Observational and retrospective study. ...BFI and predictors relationships were checked by multinom …
OBJECTIVES: Assessment of opioid-induced constipation (OIC) prevalence and relationship with demographic, clinical, and drug predictors …
Methylnaltrexone: MNTX.
[No authors listed] [No authors listed] Drugs R D. 2006;7(6):374-8. doi: 10.2165/00126839-200607060-00006. Drugs R D. 2006. PMID: 17073520 Review.
Analysis of preliminary data from 61 healthy volunteers who received methylnaltrexone at three dose levels indicated that the drug was well tolerated and exhibited predictable pharmacokinetics. Based on these phase I studies, Progenics selected an oral formulation and dose …
Analysis of preliminary data from 61 healthy volunteers who received methylnaltrexone at three dose levels indicated that the drug was well …
Naloxone Versus Methylnaltrexone for Opioid-Induced Constipation in Critically Ill Patients.
Habeeb EA, Tran LK, Goodberlet MZ, Lupi KE, DeGrado JR, Dube KM. Habeeb EA, et al. Ann Pharmacother. 2023 Jul;57(7):762-768. doi: 10.1177/10600280221132851. Epub 2022 Oct 29. Ann Pharmacother. 2023. PMID: 36314271
Naloxone administration was identified as a statistically significant predictor of BM within 48 hours (odds ratio [OR] = 2.68 [1.33-5.38]). ...
Naloxone administration was identified as a statistically significant predictor of BM within 48 hours (odds ratio [OR] = 2.68 [1.33-5 …
Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration.
Rotshteyn Y, Boyd TA, Yuan CS. Rotshteyn Y, et al. Expert Opin Drug Metab Toxicol. 2011 Feb;7(2):227-35. doi: 10.1517/17425255.2011.549824. Epub 2011 Jan 11. Expert Opin Drug Metab Toxicol. 2011. PMID: 21222554 Review.
EXPERT OPINION: Studies conducted to date indicate that methylnaltrexone has high bioavailability after subcutaneous administration at therapeutic dose levels, a terminal half-life of 8 - 9 h, minimal metabolism, elimination involving renal and non-renal routes, and a limited pot …
EXPERT OPINION: Studies conducted to date indicate that methylnaltrexone has high bioavailability after subcutaneous administration at thera …
Opioid-induced constipation in patients with cancer pain in Japan (OIC-J study): a post hoc subgroup analysis of patients with lung cancer.
Imai H, Fumita S, Harada T, Noriyuki T, Gamoh M, Okamoto M, Akashi Y, Kizawa Y, Tokoro A. Imai H, et al. Jpn J Clin Oncol. 2021 Mar 3;51(3):444-450. doi: 10.1093/jjco/hyaa186. Jpn J Clin Oncol. 2021. PMID: 33157554 Free PMC article.
Opioid-induced constipation occurred rapidly after initiating opioids and had a significant impact on Patient Assessment of Constipation Symptoms total score (P = 0.0031). Patient baseline characteristics did not appear to be predictive of opioid-induced constipation onset …
Opioid-induced constipation occurred rapidly after initiating opioids and had a significant impact on Patient Assessment of Constipation Sym …
51 results